Syneos Health Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Syneos Health heeft een totaal eigen vermogen van $3.5B en een totale schuld van $2.7B, wat de schuld-eigenvermogensverhouding op 75.8% brengt. De totale activa en totale passiva bedragen respectievelijk $8.1B en $4.6B. De EBIT Syneos Health is $342.8M waardoor de rentedekking 3.1 is. Het heeft contanten en kortetermijnbeleggingen van $91.2M.
Belangrijke informatie
75.8%
Verhouding schuld/eigen vermogen
US$2.65b
Schuld
| Rente dekkingsratio | 3.1x |
| Contant | US$91.17m |
| Aandelen | US$3.49b |
| Totaal verplichtingen | US$4.58b |
| Totaal activa | US$8.08b |
Recente financiële gezondheidsupdates
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $2.0B ) SYNH } overtreffen de korte termijn passiva ( $1.6B ).
Langlopende schulden: De kortetermijnactiva van SYNH ( $2.0B ) dekken de langetermijnschulden ( $3.0B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 73.2% ) SYNH wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van SYNH is de afgelopen 5 jaar gedaald van 101.8% naar 75.8%.
Schuldendekking: De schuld van SYNH wordt niet goed gedekt door de operationele kasstroom ( 9.5% ).
Rentedekking: De rentebetalingen op de schuld van SYNH worden goed gedekt door EBIT ( 3.1 x dekking).